David Peterhoff
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- COVID-19 Clinical Research Studies
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- SARS-CoV-2 and COVID-19 Research 17
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 detection and testing 6
-
- vaccines and immunoinformatics approaches 4
- Co-authors
- Ralf Wagner (28 shared papers)Miriam Breunig (7 shared papers)André Gessner (13 shared papers)Bernd Salzberger (8 shared papers)Oscar P. Kuipers (2 shared papers)Jingjing Deng (1 shared paper)Manuel Montalbán‐López (1 shared paper)Steven Schmitt (1 shared paper)
- Journals
- Vaccines (5 papers)Frontiers in Immunology (4 papers)European Journal of Pharmaceutics and Biopharmaceutics (3 papers)Infection (3 papers)iScience (2 papers)
- Partner nations
- GermanySwitzerlandUnited Kingdom
In The Last Decade
David Peterhoff
42 papers receiving 649 citations
Peers
Comparison fields: 5 of 74
- Infectious Diseases 264
- Virology 50
- Microbiology 41
- Molecular Biology 311
- Pharmacology 65
Countries citing papers authored by David Peterhoff
This map shows the geographic impact of David Peterhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Peterhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Peterhoff more than expected).
Fields of papers citing papers by David Peterhoff
This network shows the impact of papers produced by David Peterhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Peterhoff. The network helps show where David Peterhoff may publish in the future.
Co-authors
The 25 scholars most cited alongside David Peterhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 94 | |
| 2 | 2021 | 86 | |
| 3 | 2021 | 38 | |
| 4 | 2021 | 38 | |
| 5 | 2021 | 38 | |
| 6 | 2022 | 26 | |
| 7 | 2021 | 24 | |
| 8 | 2019 | 23 | |
| 9 | 2014 | 22 | |
| 10 | 2018 | 22 | |
| 11 | 2019 | 21 | |
| 12 | 2021 | 16 | |
| 13 | 2023 | 14 | |
| 14 | 2017 | 13 | |
| 15 | 2023 | 12 | |
| 16 | 2020 | 12 | |
| 17 | 2021 | 11 | |
| 18 | 2022 | 11 | |
| 19 | 2022 | 10 | |
| 20 | 2019 | 10 |
About David Peterhoff
David Peterhoff is a scholar working on Infectious Diseases, Molecular Biology, Virology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 42 papers that have together received 656 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (17 papers), HIV Research and Treatment (10 papers), COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 detection and testing (6 papers), Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), vaccines and immunoinformatics approaches (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Infectious Diseases (264 citations), Virology (50 citations), Microbiology (41 citations), Molecular Biology (311 citations) and Pharmacology (65 citations). David Peterhoff has collaborated with scholars based in Germany, Switzerland and United Kingdom. Frequent co-authors include Ralf Wagner, Miriam Breunig, André Gessner, Bernd Salzberger, Oscar P. Kuipers, Jingjing Deng, Manuel Montalbán‐López, Steven Schmitt, Martin Held and Bárbara Schmidt. Their work appears in journals such as Vaccines, Frontiers in Immunology, European Journal of Pharmaceutics and Biopharmaceutics, Infection and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.